Pure Holding

Pure Holding is a Swiss-based life sciences group specializing in the research, development, and production of cannabis and cannabinoid-based products. The company operates through several specialized subsidiaries, most notably Puregene, which utilizes a proprietary genomic breeding platform to develop high-performance, standardized cannabis varieties. Another key unit, Pure Pharma, focuses on the manufacturing of pharmaceutical-grade cannabinoid active pharmaceutical ingredients (APIs) under strict GMP standards. By integrating advanced genomics with large-scale cultivation and extraction, Pure Holding aims to provide consistent and high-quality cannabinoid solutions for medical and industrial applications. The group's vertically integrated model covers the entire value chain from genetic discovery to the delivery of finished pharmaceutical products.